health π©Ί Methotrexate use in IBD: real-world findings
A new cohort study examined methotrexate use in over 1100 IBD patients outside of clinical trials. Researchers analyzed data from 15 French centers covering January 2015 to December 2022. Methotrexate was mostly used as combination therapy, with a median treatment duration of 12.3 months. While adverse events occurred, serious toxicity was uncommon in the group. The study suggests real-life data is key to understanding this treatment's role. π©Ί